AOD9604 2mg – Beligas | Lab Tested Weight Management Peptide
Government-Licensed Supplier • Pharmaceutical Grade • Verified Authenticity
Nexo Vira Lab proudly offers AOD9604 2mg – Beligas, a pharmaceutical-grade anti-obesity peptide developed to support fat loss, metabolic efficiency, and body recomposition. As a government-licensed and regulated shop, all products are independently lab tested to ensure purity, identity, and safety.
Each pack contains 1 sterile vial with 2 mg of AOD-9604, manufactured by Beligas Pharmaceuticals, a globally recognized peptide manufacturer.
Browse similar compounds in our
Weight Loss Peptides Collection
Product Overview
- Substance: AOD-9604 (Anti-Obesity Drug-9604)
- Strength: 2 mg per vial
- Manufacturer: Beligas
- Warehouse: International Warehouse 3
- Aromatization: No
- Hepatotoxicity: No
- Water Retention: No
- HBR: No
- Acne: No
Available Packs & Pricing
- 1 Pack (1 vial × 2 mg): $28.00
- 5 Pack (Save $14.00): $126.00
- 10 Pack (Save $56.00): $224.00
What Is AOD 9604?
AOD 9604, also known as GH Fragment 176-191, is a modified segment of human growth hormone (HGH). While full HGH contains 191 amino acids, AOD-9604 reproduces only the final 15 amino acids (176–191) responsible for fat metabolism.
This peptide was specifically developed to deliver the fat-burning benefits of HGH without its muscle-building, insulin-altering, or hormonal side effects.
Benefits of AOD 9604 2mg
- Reduces body fat, especially stubborn abdominal fat
- Triggers fat release preferentially from obese fat cells
- Stimulates lipolysis (fat breakdown)
- Inhibits lipogenesis (fat storage)
- Mimics natural HGH fat-regulation pathways
- No adverse effects on blood sugar or growth
- Does not increase hunger or cortisol
- Supports cartilage repair and regeneration, especially when stacked with BPC-157
AOD9604 2mg – Beligas Mechanism of Action
AOD-9604 (Tyr-hGH Fragment 176–191) operates through a unique fat-oxidation pathway independent of the HGH receptor. Unlike traditional HGH or GHRP peptides, AOD-9604:
- Activates fat degradation and oxidation
- Prevents new fat accumulation
- Does not stimulate appetite
- Does not interfere with glucose metabolism
Laboratory and clinical studies conducted on rodents, pigs, dogs, and humans demonstrate that AOD-9604 preferentially targets abdominal and visceral fat, making it one of the most effective peptides for weight management.
Scientific References (NIH / PubMed)
AOD 9604 vs Other Fat-Loss Peptides
While CJC-1295 increases overall HGH levels (which may increase hunger and cortisol in some users), AOD-9604 works directly on fat metabolism without stimulating appetite.
For users whose primary goal is fat loss, AOD-9604 is often preferred over GHRPs such as GHRP-2 or GHRP-6.
Research & Development Background
AOD-9604 was developed in the 1990s by Professor Frank Ng at Monash University (Australia) to create an anti-obesity compound with the fat-burning effects of HGH without anabolic activity.
Ongoing and completed trials have explored its potential applications in:
- Obesity management
- Osteoarthritis
- Hypercholesterolemia
- Bone and cartilage repair
Clinical data confirms that oral glucose tolerance remains unaffected, no antibodies were detected, and no serious adverse events occurred during trials.
Safety & Tolerability
AOD9604 2mg – Beligas demonstrated an excellent safety profile, indistinguishable from placebo in clinical studies.
✔ No liver toxicity
✔ No hormonal suppression
✔ No blood sugar disruption
✔ No aromatization
AOD-9604 has obtained Human GRAS (Generally Recognized as Safe) status in the USA.
Why Buy AOD9604 2mg – Beligas from Nexo Vira Lab?
✅ Government-licensed supplier
✅ Independent third-party lab testing
✅ Authentic Beligas products
✅ Secure checkout & discreet shipping
✅ Transparent quality standards
Reviews
There are no reviews yet.